Old Web
English
Sign In
Acemap
>
authorDetail
>
Ajalaya Teyateeti
Ajalaya Teyateeti
University of Texas MD Anderson Cancer Center
Medicine
Hormonal therapy
Radiology
PET-CT
Prostate cancer
4
Papers
11
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Survival Outcomes for Yttrium-90 Transarterial Radioembolization With and Without Sorafenib for Unresectable Hepatocellular Carcinoma Patients.
2020
Journal of Hepatocellular Carcinoma
Ajalaya Teyateeti
Armeen Mahvash
James P. Long
Mohamed Abdelsalam
Rony Avritscher
Beth Chasen
Ahmed Omar Kaseb
J. Kuban
Ravi Murthy
Bruno C. Odisio
Achiraya Teyateeti
Homer A. Macapinlac
S. Cheenu Kappadath
Show All
Source
Cite
Save
Citations (5)
Is There Any Role for 18F-Fluciclovine PET/CT in the Presence of Undetectable PSA in Prostate Cancer Patients After Definitive Treatment?
2020
Clinical Nuclear Medicine
Ajalaya Teyateeti
Achiraya Teyateeti
Homer A. Macapinlac
Yang Lu
Show All
Source
Cite
Save
Citations (2)
Diagnostic performance of F-18 fluciclovine PET/CT in post-radical prostatectomy prostate cancer patients with rising prostate-specific antigen level ≤0.5 ng/mL.
2020
Nuclear Medicine Communications
Ajalaya Teyateeti
Bilal Khan
Achiraya Teyateeti
Bo Chen
Jidapa Bridhikitti
Tinsu Pan
Wei Peng
Homer A. Macapinlac
Yang Lu
Show All
Source
Cite
Save
Citations (3)
1